Ref.: BL-RE-090804Manufacturer ref.: EHSERPINA1X10 10 x 96 tests
€4,815.00 excl. VAT
The alpha-1-AT is synthesized in the liver and acts as an inhibitor of proteases such as trypsin, leelastase, chymotrypsin, collagenase, leukocyte proteases, plasmine and thrombin, which can be released during liver...
Accession number
P01009
Dose range
2.05 to 500 ng/ml
Sensitivity of the dosage
2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
The alpha-1-AT is synthesized in the liver and acts as an inhibitor of proteases such as trypsin, leelastase, chymotrypsin, collagenase, leukocyte proteases, plasmine and thrombin, which can be released during liver...
The alpha-1-AT is synthesized in the liver and acts as an inhibitor of proteases such as trypsin, l-elastase, chymotrypsin, collagenase, leukocyte proteases, plasmine and thrombin, which can be released during inflammatory reactions in the lung. In the absence of alpha-1-AT, these enzymes are not inhibited and may digest pulmonary parenchyma. Alpha-1-AT deficiency is associated with chronic obstructive bronchopneumopathy (emphysema) and less frequently with hepatic cirrhosis in infants and respiratory distress of the newborn. The increase in alpha-1-AT occurs as an acute phase response to necrosis and inflammation of tissues. Serum levels of alpha-1-AT are high in rheumatoid arthritis, bacterial infection, vasculitis and carcinoma.
Sensitivity
Sensitivity of the dosage: 2 ng/ml.
Measurement range
Dosing range: 2.05 to 500 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.